Brief: Adamis Pharmaceuticals Announces Results Of Tempol In Omicron Virus Challenge In Hamster Model

DMK Pharmaceuticals

22/03/2022 11:48

March 22 (Reuters) - Adamis Pharmaceuticals Corp  ADMP.O :
    * ADAMIS PHARMACEUTICALS ANNOUNCES RESULTS OF TEMPOL IN
OMICRON
VIRUS CHALLENGE IN HAMSTER MODEL
    * ADAMIS PHARMACEUTICALS CORP - IN OUR HAMSTER MODEL USING
HIGH
DOSES OF OMICRON VIRUS, WE OBSERVE SIGNIFICANT PULMONARY
INFLAMMATION
    * ADAMIS PHARMACEUTICALS CORP - RECENT TEMPOL ANIMAL STUDY
SHOWS
SIGNIFICANT DECREASE IN LUNG INFLAMMATION IN HAMSTERS GIVEN HIGH
DOSES OF OMICRON
    * ADAMIS PHARMACEUTICALS CORP - ANIMAL STUDY RESULTS TO DATE
SUPPORT DESIGN OF OUR ONGOING CLINICAL STUDY IN HUMANS

Source text for Eikon:  ID:nGNX63ghW8 
Further company coverage:  ADMP.O 

 ((Reuters.Briefs@thomsonreuters.com;))